The global effort against breast cancer has already had major victories, but women with the disease need even more. With input from the fields of epidemiology, genomics, immunology and molecular biology, scientists are looking for the advances that could turn even more people with breast cancer into survivors.
Nature is pleased to acknowledge financial support from the Medipolis Proton Therapy and Research Center (MPTRC) in producing this Outlook. The sponsor retains sole responsibility for the following messages.
The Medipolis Proton Therapy and Research Center is located in Ibusuki City, Kagoshima Prefecture, which is known as one of Japan’s best hot spring resort areas. The ideology and vision of MPTRC is as follows:
To provide proton therapy in a resort-type setting.
To offer compassionate and uplifting medical care.
To continuously improve the quality and safety of the medical care offered.
To develop new proton therapies for cancers that are difficult to treat by x-ray, including pancreatic cancer and breast cancer.
In 2011, we began research on the use of proton therapy to treat small cancerous tumours of the breast. We have developed a unique stabilization system called Medipolis Technique (MPT) and began treatment of the first breast cancer patient using MPT in June 2015.
As of August 2015, more than 1,500 cancer patients have been treated at MPTRC. Of these, more than 140 patients with locally advanced pancreatic cancer have been successfully treated, resulting in prolonged prognosis with a reduction in pain.
MPTRC was accredited by the Joint Commission International (JCI) in September of 2013, the first research centre in Japan designated as a proton therapy facility.